Functional characterization revealed that TCN1 enhances pancreatic cancer cell proliferation, migration, invasion, and epithelial–mesenchymal transition (EMT) in both in vitro and in vivo models, thereby accelerating tumor progression. Here, TCN1 is linked to familial pancreatic carcinoma.